New targeted drug trial offers hope for Tough-to-Treat liver cancer
Disease control
Not yet recruiting
This study is testing an experimental drug called BB102 for people with advanced liver cancer that has worsened despite standard treatments. The goal is to see if the drug can shrink tumors and control the cancer's growth. About 60 participants with a specific type of liver cance…
Phase: PHASE2 • Sponsor: Broadenbio Ltd., Co. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC